Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
This study has been completed.
Study NCT00000542. Last updated on April 22, 2008.
Information provided by National Heart, Lung, and Blood Institute (NHLBI)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Coronary Disease
Diabetes Mellitus
Heart Diseases
Hypercholesterolemia
Hypertension
Myocardial Infarction
Myocardial Ischemia
Heart Failure
Additional conditions recognized in this trial
Coronary Artery Disease
Infarction
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Dyslipidemias
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Inhibitors, ACE
amlodipine
lisinopril
doxazosin
chlorthalidone
pravastatin
diet, fat-restricted
More general drug interventions related to this trial
Angiotensin-Converting Enzyme Inhibitors
Anticholesteremic Agents
Antihypertensive Agents
Antilipemic Agents
Antimetabolites
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Diuretics
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Sodium Chloride Symporter Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content